Loading...
Cipher Pharmaceuticals Inc.
CPHRF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$9.21
$0.09(0.94%)
Cipher Pharmaceuticals Inc. (CPHRF) Financial Performance & Income Statement Overview
Review Cipher Pharmaceuticals Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
57.66%
↑ 57.66%
Operating Income Growth
-31.93%
↓ 31.93%
Net Income Growth
-43.36%
↓ 43.36%
Operating Cash Flow Growth
22.17%
↑ 22.17%
Operating Margin
19.13%
↑ 19.13%
Gross Margin
71.95%
↑ 71.95%
Net Profit Margin
23.40%
↑ 23.40%
ROE
9.36%
↑ 9.36%
ROIC
5.20%
↑ 5.20%
Cipher Pharmaceuticals Inc. (CPHRF) Income Statement & Financial Overview
Review Cipher Pharmaceuticals Inc.'s (CPHRF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $11.82M | $10.37M | $5.30M | $5.87M |
| Cost of Revenue | $5.13M | $1.97M | $1.11M | $1.05M |
| Gross Profit | $6.69M | $8.40M | $4.20M | $4.81M |
| Gross Profit Ratio | $0.57 | $0.81 | $0.79 | $0.82 |
| R&D Expenses | $0.00 | $0.00 | $47000.00 | $45000.00 |
| SG&A Expenses | $4.85M | $4.61M | $1.32M | $1.42M |
| Operating Expenses | $6.36M | $4.61M | $1.61M | $1.76M |
| Total Costs & Expenses | $11.49M | $6.58M | $2.71M | $2.81M |
| Interest Income | $0.00 | $0.00 | $611000.00 | $555000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $1.51M | $1.93M | $292000.00 | $289000.00 |
| EBITDA | $1.84M | $3.79M | $2.88M | $3.34M |
| EBITDA Ratio | $0.16 | $0.37 | $0.54 | $0.57 |
| Operating Income | $334000.00 | $3.79M | $2.88M | $3.06M |
| Operating Income Ratio | $0.03 | $0.37 | $0.54 | $0.52 |
| Other Income/Expenses (Net) | -$3.19M | -$3.47M | -$366000.00 | -$376000.00 |
| Income Before Tax | -$2.85M | $326000.00 | $2.52M | $2.97M |
| Income Before Tax Ratio | -$0.24 | $0.03 | $0.47 | $0.51 |
| Income Tax Expense | -$6.20M | $43000.00 | -$480000.00 | -$1.96M |
| Net Income | $3.34M | $283000.00 | $3.00M | $4.92M |
| Net Income Ratio | $0.28 | $0.03 | $0.56 | $0.84 |
| EPS | $0.13 | $0.01 | $0.12 | $0.21 |
| Diluted EPS | $0.14 | $0.01 | $0.12 | $0.20 |
| Weighted Avg Shares Outstanding | $24.96M | $24.96M | $24.96M | $23.99M |
| Weighted Avg Shares Outstanding (Diluted) | $24.57M | $24.57M | $24.57M | $24.40M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan